The introduction of new vaccines into developing countries

被引:78
|
作者
Mahoney, RT [1 ]
Maynard, JE
机构
[1] Int Vaccine Inst, Seoul, South Korea
[2] Seoul Natl Univ, Int Task Force Hepatitis B Immunizat, Seoul 151742, South Korea
[3] Program Appropriate Technol Hlth, Seattle, WA USA
[4] Int Task Force Hepatitis B Immunizat, Seattle, WA 98104 USA
关键词
vaccine introduction; hepatitis B; developing countries;
D O I
10.1016/S0264-410X(98)00246-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development and introduction of new vaccines is a costly and time consuming process. Unfortunately, those most in need -individuals in developing countries- are the last to receive these powerful disease preventing products. From the time a vaccine is first licensed in a developed country to the time most of the poor ill developing countries have access to the vaccine can be 20-30 years. This delay is unacceptable. There is a great need to reduce this time span. This paper examines five ways of reducing the time span. Each of the five is essential and achieving success on all five will require a heightened level of international effort and coordination. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:646 / 652
页数:7
相关论文
共 50 条
  • [31] Veterinary vaccines and their use in developing countries
    Lubroth, J.
    Rweyemamu, M. M.
    Viljoen, G.
    Diallo, A.
    Dungu, B.
    Amafu, W.
    [J]. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2007, 26 (01): : 179 - 201
  • [32] Cervical cancer vaccines for developing countries
    Jones, Jonathan Spencer
    [J]. SAJOG-SOUTH AFRICAN JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 12 (03): : 111 - 111
  • [33] Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World
    McElligott, Sean
    [J]. AMERICAN JOURNAL OF LAW & MEDICINE, 2009, 35 (2-3) : 415 - 441
  • [34] Developing New Vaccines
    Hotez, Peter Jay
    [J]. AMERICAN SCIENTIST, 2020, 108 (05) : 267 - 268
  • [35] Globalization and developing countries: introduction
    Mitra, Devashish
    Ranjan, Priya
    [J]. INDIAN GROWTH AND DEVELOPMENT REVIEW, 2013, 6 (01) : 259 - 274
  • [36] Manufacturing costs of HPV vaccines for developing countries
    Clendinen, Chaevia
    Zhang, Yapei
    Warburton, Rebecca N.
    Light, Donald W.
    [J]. VACCINE, 2016, 34 (48) : 5984 - 5989
  • [37] A cost analysis of producing vaccines in developing countries
    Munira, Syarifah Liza
    Hendriks, Jan T.
    Atmosukarto, Ines I.
    Friede, Martin H.
    Carter, Louise M.
    Butler, James R. G.
    Clements, Archie C. A.
    [J]. VACCINE, 2019, 37 (09) : 1245 - 1251
  • [38] Cervical Cancer and HPV Vaccines in Developing Countries
    Zarchi, Mojgan Karimi
    Behtash, Nadereh
    Chiti, Zohreh
    Kargar, Saeed
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 969 - 974
  • [39] Impact of Hib conjugate vaccines in developing countries
    Riedmann, Eva M.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (09) : 1828 - 1828
  • [40] How to encourage the production of vaccines for developing countries?
    Meniri, Sami
    Legeard, Pierre
    Sabatier, Valerie
    [J]. BIOFUTUR, 2013, (348) : 54 - 57